Hepatic cryotherapy: State-of-the-art techniques and future developments

Ultrasound Quarterly

Volumn 14, Issue 3, 1998, Pages 171-188

  Littrup, Peter J ^a,d   Lee Jr , Fred T ^b   Rajan, Dheeraj ^a   Meetze, Kyle ^a   Weaver, Donald ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b University of Wisconsin Health   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Cryosurgery; Cryotherapy; Hepatic neoplasms; Intraoperative ultrasound

Indexed keywords

CRYOTHERAPY; HUMAN; LIVER TUMOR; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 0031718983     PISSN: 08948771     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013644-199809000-00005     Document Type: Review

References (89)

1. Landis SH, Murray T, Boiden S, Wingo PA. Cancer statistics 1998. CA Cancer J Clin 1998;48:6-29.
2. Zhou XD, Tang ZY, Yu YQ. Ablative approach for primary liver cancer: Shanghai experience. Surg Oncol Clin N Am 1996;5: 379-90.
3. Nagasue N, Yukada K, Hamada T. The natural history of hepatocellular carcinoma: a study of 100 untreated cases. Cancer 1984; 54:1461-5.
4. Falkson G, Cnaan A, Schutt AJ, et al. Prognosis factors for survival in hepatocellular carcinoma. Cancer Res 1988;48:7314-8.
5. Bismuth H, Chinche L. Comparison of hepatic resection and transplantation in the treatment of liver cancer. Semin Surg Oncol 1993;9:341-5.
6. Farmer DG, Rososve MH, Shaked A. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994;219:59-71.
7. Onodera H, Ukai K, Minami Y. Hepatocellular carcinoma cases with five-year survival and prognostic factors affecting the survival time. Tohoku J Exp Med 1995;176:203-11.
8. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival. Cancer 1996;77:2217-22.
9. Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986;150:195-203.
10. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer: biologic perspectives. Ann Surg 1989;210: 127-38.
11. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver, I: the prognosis for patients with hepatic metastases from colonic carcinoma by laparotomy. Cancer 1969;23:198-202.
12. Ravikumar TS, Steele GD Jr, Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res 1991;51:6323-7.
13. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285-8.
14. Bengtsson G, Caelsson G, Hafstrom L, Jonsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981;141:586-9.
15. MacDonald JS, Kisner DF, Smythe Y, et al. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer phase II study utilizing weekly 5-FU. Cancer Treat Rep 1976;60:1597-1600.
16. Buroker T, Kim PN, Groppe C, et al. 5-FU infusion with mitomycin-C versus 5-FU infusion with methyl CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study. Cancer 1978;42:1228-33.
17. Grage TB, Vassilopoulos PP, Shingleton WW, et al. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: a Central Oncology Group Study. Surgery 1979;86:550-5.
18. Petrelli N, Herrera L, Rustum Y, et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 1987;5:1559-65.
19. Doroshow JH, Multhauf P, Leone L, et al. Prospective randomized comparison of fiuorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 1990;8:491-501.
20. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996;88:252-8.
21. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection - Registry of Hepatic Metastases. Surgery 1988;103:278-88.
22. Fortner JG. Recurrence of colorectal cancer after hepatic resection. Am J Surg 1988;155:378-82.
23. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991;110:13-29.
24. Steele G Jr, Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D. A prospective evaluation of hepatic resection for colorectal metastases to the liver Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 1991;9:1105-12. Comment 2078-9.
25. Savage AP, Malt RA. Survival after hepatic resection for malignant tumors. Br J Surg 1992;79:1095-1101.
26. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216:493-504.
27. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer analysis of clinical and pathologic risk factors. Surgery 1994;16:703-10.
28. Sheu JC, Sung JL, Chen DS, et al. Ultrasonography of small hepatic rumors using high-resolution linear-array real-time instruments. Radiology 1984;150:797-802.
29. Stephenson KR, Steinberg SM, Hughes KS, Vetto JT, Sugarbaker PH, Chang AE. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg 1988;208: 679-87.
30. Cunningham JD, Fong Y, Shriver C, et al. One hundred consecutive hepatic resections: blood loss, transfusion, and operative technique. Arch Surg 1994;129:1050-6.
31. Agarwal N, Murphy JG, Cayten CG, Stahl WM. Blood transfusion increases risk of infection after trauma. Arch Surg 1993;18: 171-7.
32. Cooper IS. Cryogenic surgery: a new method of destruction or extirpation of benign or malignant tissues. N Engl J Med 1963; 268:743-9.
33. Onik GM, Cooper C, Goldberg HI, Moss AA, Rubinsky B, Christianson M. Ultrasonic characteristics of frozen liver. Cryobiology 1984;21:321-8.
34. Onik GM, Gilbert J, Hoddick W, Filly R, Callen P, Rubinsky B. Sonographic monitoring of hepatic cryosurgery in an experimental animal model. AJR Am J Roentgenol 1985;144:1043-7.
35. Zhou XD, Tang ZY, Yu YQ, Ma ZC. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Cancer 1988;61: 1889-92.
36. Rubinsky B, Lee CY, Bastacky J, Onik GM. The process of freezing and the mechanism of damage during hepatic cryosurgery. Cryobiology 1990;27:85-97.
37. Tatsutani K, Rubinsky B, Onik G, Dahiya R. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology 1996;48:441-7.
38. Weber SM, Lee FT Jr, Chinn DO, Warner TF, Chosy SG, Mahvi DM. Perivascular and intralesional tissue necrosis after hepatic cryoablation: results in a porcine model. Surgery 1997;122: 742-7.
39. Staren ED, Sabel MS, Gianakakis LM, et al. Cryosurgery of breast cancer. Arch Surg 1997;132:28-33.
40. Lee FT Jr, Mahvi DM, Chosy SG, et al. Hepatic cryosurgery with intraoperative ultrasound guidance. Radiology 1997;202:624-32.
41. Kruskal JB, Kane RA. Intraoperative ultrasonography of the liver. Crit Rev Diagn Imaging 1995;36:175-226.
42. Ravikumar TS, Steele GD Jr. Hepatic cryosurgery. Surg Clin North Am 1989;69:433-40.
43. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in the treatment of unresectable metastases. Surg Oncol 1995;4:231-6.
44. Soyer P, Elias D, Zeitoun G, Roche A, Levesque M. Surgical treatment of hepatic metastases: impact of intraoperative ultrasound. AJR Am J Roentgenol 1993;160:511-4.
45. Haider MA, Leonhardt C, Hanna SS, Tennenhouse J. The role of intraoperative ultrasonography in planning the resection of hepatic neoplasms. Can Assoc Radiol J 1995;46:98-104.
46. Ravikumar TS, Buenaventura S, Salem RR, D'Andrea B. Intraoperative ultrasonography of the liven detection of occult liver tumors and treatment by cryosurgery. Cancer Detect Prev 1994; 18:131-8.
47. Gage AA. Current progress in cryosurgery. Cryobiology 1988;25: 483-6.
48. Makuuchi M, Takayama T, Kosuge T, et al. The value of ultrasonography for hepatic surgery. Hepatogastroenterology 1991;38: 64-70.
49. Lee FT Jr, Weber SM, Chosy SG, Warner TF, Mahvi DM. Hepatic cryoabiation: ultrasound monitoring accurately predicts the extent of necrosis in normal pig liver. Radiology, 1998;207:73-7.
50. Littrup PJ, Mody A, Sparschu RA, et al. Prostatic cryotherapy: ultrasonographic and pathologic correlation in the canine model. Urology 1994;44:175-84.
51. Hewitt PM, Zhao J, Akhter J, Morris DL. A comparative laboratory study of liquid nitrogen and argon gas cryosurgery systems. Cryobiology 1997;35:303-8.
52. Cozzi PJ, Stewart GJ, Morris DL. Thrombocytopenia after hepatic cryotherapy for colorectal metastases: correlates with hepatocellular injury. World J Surg 1994;18:774-7.
53. Kuszyk BS, Choti MA, Urban BA, et al. Hepatic rumors treated by cryosurgery: normal CT appearance. AJR Am J Roentgenol 1996;166:363-7.
54. Ravikumar TS, Kane R, Cady B, et al. A 5 year study of cryosurgery in the treatment of liver tumors. Arch Surg 1991;126: 1520-4.
55. Onik G, Rubinsky B, Zemel R, et al. Ultrasound-guided hepatic cryosurgery in the treatment of colorectal metastatic colon carcinoma: preliminary results. Cancer 1991;67:901-7.
56. Onik GM, Atkinson D, Zemel R, Weaver ML. Cryosurgery of liver cancer. Semin Surg Oncol 1993;9:309-17.
57. Zhou XD, Tang ZY, Yu YQ, et al. The role of cryosurgery in me treatment of hepatic cancer a report of 113 cases. J Cancer Res Clin Oncol 1993;120:100-2.
58. Kane RA. Ultrasound-guided hepatic cryosurgery for tumor ablation. Semin Intervent Radiol 1993;10:132-42.
59. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer 1995;76:210-14.
60. Morris DL, Ross WB, Iqbal J, McCall JL, King J, Clingan PR. Cryoablation of hepatic malignancy: an evaluation of tumor marker data and survival in 110 patients. GI Cancer 1996;1:247-51.
61. Shafir M, Shapiro R, Sung M, et al. Cryoabiation of unresectable malignant liver tumors. Am J Surg 1997;171:27-31.
62. Redlich PN, Baker EJ, McAuliffe TL, Quebbeman EJ. Surgical management of colorectal metastases to the liver role of resection and cryosurgery Wisc Med J 1996;95:859-63.
63. McKinnon JG, Temple WJ, Wiseman DA, Saliken JC. Cryosurgery for malignant tumours of me liver. Can J Surg 1996;39:401-6.
64. Adam R, Akpinar E, Johann M, Kuntslinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997;25:39-50.
65. Wren SM, Coburn MM, Tan M, et al. Is cryosurgical ablation appropriate for treating hepatocellular cancer? Arch Surg 1997; 132:599-603
66. Crews KA, Kuhn JA, McCarty TM, Fisher TL, Goldstein RM, Preskin JT. Cryosurgical ablation of hepatic tumors. Am J Surg 1997;174:614-7.
67. Korpan NN. Hepatic cryosurgery for liver metastases. Ann Surg 1997;225:193-201.
68. Johnson LB, Krebs TL, Van Echo D, et al. Cytoablative therapy with combined resection and cryosurgery for limited bilobar hepatic colorectal metastases. Am J Surg 1997;174:610-3.
69. Grampsas SA, Miller GJ, Crawford ED. Salvage prostatectomy after failed transperoneal cryotherapy: histologic findings from prostate whole-mount specimens correlated with interoperative transrectal ultrasound images. Urology 1995;45:936-41.
70. Seifert JK, Dutkowski P, Junginger T, Morris DL. Bile duct warmer in hepatic cryosurgery: a pig liver model. Cryobiology 1997;35:299-302.
71. Ravikumar TS. The role of cryotherapy in the management of patients with liver tumors. Adv Surg 1996;30:281-91.
72. Liu JB, Feld RI, Goldberg BB, et al. Laparoscopic gray-scale and color Doppler US: preliminary animal and clinical studies. Radiology 1995;194:851-7.
73. Cozzi PJ, McCall JL, Jorgensen JO, Morris DL. Laparoscopic vs. open ultrasound of the liver an in vitro study. HPB Surgery 1996; 10:87-9.
74. Lee FT Jr, Chosy SG, Weber SM, Littrup PJ, Warner TF, Mahvi DM. Hepatic cryosurgery via minilaparotomy in a pig model. J Laparoendosc Surg In press.
75. Livraghi T, Vettori C, Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology 1991;179: 709-12.
76. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8.
77. Hill CR, ter Haar GR. High intensity focused ultrasound: potential for cancer treatment. Br J Radiol 1995;68:1296-1303.
78. Amin Z, Donald JJ, Masters A. Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology 1993;187:339-47.
79. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997;202:195-203.
80. Hahn PF, Gazelle GS, Jian DY, Compton CC, Goldberg SN, Mueller PR. Liver tumor ablation: real-time monitoring with dynamic CT. Acad Radiol 1997;4:634-8.
81. Vallancien G, Harouni M, Veillon B, et al. Focused extra-corporeal pyrotherapy: feasibility study in man. J Endourol 1992;6: 173-81.
82. Rossi S, DiStasi M, Buscarini E. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759-68.
83. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radio frequency using multiprobe arrays. Acad Radiol 1995;2:670-4.
84. Goidberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996;3:636-44.
85. Livragbi T, Goidberg SN, Monti F, et al. Saline-enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997;202:205-10.
86. Saliken JC, McKinnon JG, Gray R. CT for monitoring cryotherapy. AJR Am J Roentgenol 1996;166:853-5.
87. Matsumoto R, Selig AM, Colucci VM, Jolesz FA. MR monitoring during cryotherapy in the liven predictability of histologic outcome. J Magn Reson Imaging 1993;3:770-6.
88. Pease GR, Wong ST, Roos MS, Rubinsky B. MR image-guided control of cryosurgery. J Magn Reson Imaging 1995;5:753-60.
89. Hong JS, Wong S, Pease G, Rubinsky B. MR imaging assisted temperature calculations during cryosurgery. Magn Reson Imaging 1994;12:1021-31.